UNSPSC 51391707: Etilefrine

This classification denotes an adrenergic agent with the molecular formula C10H15NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZB6F8MY53V, chemically known as benzyl alcohol, alpha-((ethylamino)methyl)-m-hydroxy- but generally known as etilefrin, which bears US NIH Compound Identifier 3306. European Medicines Agency schedules Etilefrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07303MIG.

UNSPSC 51391707 Etilefrine, a Commodity code, covers pharmaceutical products and related medical supplies that state and local health agencies procure for emergency response, community health initiatives, and prescription management programs. Recent solicitations show state and local governments buying naloxone (an opioid antagonist), drug deactivation systems, and related prescription fulfillment capabilities through both competitive bidding and exploratory procurement mechanisms. The issuing bodies include county health departments and state health and human services commissions pursuing direct-purchase and direct-to-manufacturer pharmacy programs to manage costs and improve distribution efficiency.

Activity under this code spans Florida and Texas, with the most recent opportunities posted in mid-2026. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through July 26, 2026, with quarterly deliveries to the Seminole County Community Health Building in Sanford and potential FEMA funding. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor capabilities on direct-to-manufacturer prescription programs for state employee and retiree health plans, framed as early-stage market intelligence rather than a formal competitive solicitation. Both solicitations require vendors to meet standard compliance and insurance requirements; the Seminole County procurement specifies a two-year initial term with one-year renewal option and a three-month probationary period terminable at will.